{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:25:37Z","timestamp":1791159937858,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.plefa.2004.03.021","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T19:10:35Z","timestamp":1090609835000},"page":"277-288","source":"Crossref","is-referenced-by-count":50,"title":["Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues\u2014a comparative immunohistochemical study"],"prefix":"10.1016","volume":"71","author":[{"given":"Sumana","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parimal","family":"Bhattacherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2004.03.021_BIB1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI200113455","article-title":"Genetic and pharmacological analysis of prostanoid receptor function","volume":"108","author":"Narumiya","year":"2001","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.plefa.2004.03.021_BIB2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0014-4835(75)90031-7","article-title":"Inhibition of increased permeability of the blood\u2013aqueous barrier by non-steroidal anti-inflammatory compounds as demonstrated by fluorescein angiography","volume":"21","author":"Bhattacherjee","year":"1975","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.plefa.2004.03.021_BIB3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-4835(90)90175-T","article-title":"Further investigation into the ocular effects of prostaglandin E2, leukotriene B formyl-methionyl-leucyl phenylalanine","volume":"51","author":"Bhattacherjee","year":"1990","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.plefa.2004.03.021_BIB4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0162-3109(78)90008-5","article-title":"Cellular aspects of conjunctival inflammation induced by synergistic action histamine and prostaglandins","volume":"1","author":"Wirostko","year":"1978","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.plefa.2004.03.021_BIB5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-4835(77)90168-3","article-title":"Histamine, prostaglandins and ocular inflammation","volume":"24","author":"Eakins","year":"1977","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.plefa.2004.03.021_BIB6","series-title":"The Ocular Effects of Prostaglandins and Other Eicosanoids","first-page":"171","article-title":"The putative and demonstrated mitotic effects of Prostaglandins in mammals","author":"Miranda","year":"1989"},{"key":"10.1016\/j.plefa.2004.03.021_BIB7","series-title":"The Ocular Effects of Prostaglandins and Other Eicosanoids","first-page":"155","article-title":"Vasodyanamic and Angiogeniceffects of eicosanoids in the eye","author":"Sternschantz","year":"1989"},{"key":"10.1016\/j.plefa.2004.03.021_BIB8","series-title":"The Ocular Effects of Prostaglandins and Other Eicosanoids","first-page":"349","article-title":"The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals","author":"Bito","year":"1989"},{"key":"10.1016\/j.plefa.2004.03.021_BIB9","series-title":"The Ocular Effects of Prostaglandins and Other Eicosanoids","first-page":"447","article-title":"Effects of topically applied PGF2 a and its isopropyl ester on normal and glaucomatous human eyes","author":"Alm","year":"1989"},{"issue":"6","key":"10.1016\/j.plefa.2004.03.021_BIB10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0952-3278(97)90597-4","article-title":"Generation of second messengers by prostanoids in the iris-sphincter and ciliary muscles of cows, cats and humans","volume":"56","author":"Bhattacherjee","year":"1997","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"8","key":"10.1016\/j.plefa.2004.03.021_BIB11","first-page":"51","article-title":"Optimization of RNA isolation from human ocular tissues and analysis of prostanoid receptor mRNA expression using RT-PCR","volume":"13","author":"Kyveris","year":"2002","journal-title":"Mol. Vis"},{"key":"10.1016\/j.plefa.2004.03.021_BIB12","doi-asserted-by":"crossref","unstructured":"M.R. Hellberg, M.A. McLaughlin, N.A. Sharif, L. De Santis, T.R. Dean, E.P. Kyba, J.E. Bishop, P.G. Klimko, P.W. Zinke, R.D. Selliah, G. Barnes, J. DeFaller, A. Koyhe, T. Landry, E.K. Sullivan, R. Andrew, A.A. Davis, L. Silver, M.V. Bergamini, S. Robertson, A.L. Weiner, V.L. Sally, Identification and characterization of the ocular hypotensive efficacy of travopost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist, Surv. Ophthalmol. (2002) (Suppl 1) S13\u2013S33.","DOI":"10.1016\/S0039-6257(02)00293-X"},{"issue":"1","key":"10.1016\/j.plefa.2004.03.021_BIB13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/jpet.102.042556","article-title":"Real-time intracellular Ca2+ mobilization by travopost acid, bimatoprost, unoprostone and other analogs via endogenous mouse, rat and cloned human FP prostaglandin receptors","volume":"304","author":"Kelly","year":"2003","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.plefa.2004.03.021_BIB14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1006\/exer.1999.0829","article-title":"Localization of prostaglandin E receptor Subtypes in the ciliary Body of mouse eye","volume":"70","author":"Takamatsu","year":"2000","journal-title":"Exp. Eye Res"},{"issue":"3","key":"10.1016\/j.plefa.2004.03.021_BIB15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1076\/ocii.10.3.187.15601","article-title":"Blood\u2013aqueous barrier in prostaglandin EP2 receptor knockout mice","volume":"10","author":"Bhattacherjee","year":"2002","journal-title":"Ocular Immunol. Inflammat"},{"issue":"5","key":"10.1016\/j.plefa.2004.03.021_BIB16","first-page":"1475","article-title":"Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues","volume":"43","author":"Schlotzer-Schrehardt","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"issue":"2","key":"10.1016\/j.plefa.2004.03.021_BIB17","first-page":"424","article-title":"Localization of EP1 and FP receptors in human ocular tissues by in situ hybridization","volume":"42","author":"Mukhopadhyay","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"issue":"3","key":"10.1016\/j.plefa.2004.03.021_BIB18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/jop.1995.11.421","article-title":"Prostaglandin E2 receptor subtypes in porcine ocular tissues. I Uveal tissues","volume":"11","author":"Zhao","year":"1995","journal-title":"J. Ocular Pharmacol. Ther"},{"issue":"9","key":"10.1016\/j.plefa.2004.03.021_BIB19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0006-2952(97)00011-7","article-title":"Detection of EP2, EP4 and FP receptors in human ciliary epithelial and ciliary muscle cells","volume":"53","author":"Mukhopadhyay","year":"1997","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.plefa.2004.03.021_BIB20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-6980(92)90013-J","article-title":"Prostaglandin E2 binding site distribution and subtype classification in the rabbit iris\u2013ciliary body","volume":"44","author":"Csukas","year":"1992","journal-title":"Prostaglandins"},{"issue":"6","key":"10.1016\/j.plefa.2004.03.021_BIB21","first-page":"1109","article-title":"Prostaglandin E2 binding sites in bovine iris\u2013ciliary body","volume":"31","author":"Bhattacherjee","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1016\/j.plefa.2004.03.021_BIB22","first-page":"545","article-title":"Intraocular pressure effects of selective prostanoid receptor agonists involve different subtypes according to radioligand binding studies","volume":"6","author":"Woodward","year":"1993","journal-title":"J. Lipid Med"},{"key":"10.1016\/j.plefa.2004.03.021_BIB23","first-page":"3047","article-title":"Responses of intraocular pressure and the pupil of feline eyes to prostoglandin EP1 and FP receptor agonists","volume":"40","author":"Bhattacherjee","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"issue":"3","key":"10.1016\/j.plefa.2004.03.021_BIB24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/jop.1995.11.447","article-title":"Molecular characterization and ocular hypotensive properties of the prostanoid EP2 receptor","volume":"11","author":"Woodward","year":"1995","journal-title":"J. Ocular Pharmacol. Ther"},{"issue":"11","key":"10.1016\/j.plefa.2004.03.021_BIB25","first-page":"2463","article-title":"Prostanoid-induced blood\u2013aqueous barrier breakdown in rabbits involves the EP2 receptor subtype","volume":"31","author":"Protzman","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"issue":"3","key":"10.1016\/j.plefa.2004.03.021_BIB26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0021-5155(01)00320-3","article-title":"Effects of tetramethylpyrazine on prostaglandin E (2) and prostaglandin E (2) receptor agonist induced disruption of blood aqueous barrier in pigmented rabbits","volume":"45","author":"Kitagawa","year":"2001","journal-title":"Jpn. J. Ophthalmol"},{"key":"10.1016\/j.plefa.2004.03.021_BIB27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1139\/y94-026","article-title":"Reduced responses of retinal vessels of the newborn pig to prostaglandins but not to thromboxane","volume":"72","author":"Abran","year":"1994","journal-title":"Can. J. Physiol. Pharmacol"},{"key":"10.1016\/j.plefa.2004.03.021_BIB28","doi-asserted-by":"crossref","first-page":"R995","DOI":"10.1152\/ajpregu.1997.272.3.R995","article-title":"Regulation of prostanoid vasomotor effects and receptors in choroidal vessels of newborn pigs","volume":"272","author":"Abran","year":"1997","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol"},{"key":"10.1016\/j.plefa.2004.03.021_BIB29","first-page":"463","article-title":"Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development","volume":"80","author":"Abran","year":"1997","journal-title":"Circ. Res"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327804000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327804000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T13:23:23Z","timestamp":1549373003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327804000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0952327804000845"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2004.03.021","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}